Crestwood Advisors Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
7,771
+305
+4% +$22.8K 0.01% 400
2025
Q4
$589K Buy
7,466
+1,368
+22% +$108K 0.01% 360
2025
Q3
$502K Sell
6,098
-109
-2% -$8.58K 0.01% 360
2025
Q2
$499K Buy
6,207
+503
+9% +$38.8K 0.01% 349
2025
Q1
$458K Sell
5,704
-26
-0.5% -$2.16K 0.01% 355
2024
Q4
$469K Buy
5,730
+994
+21% +$82.7K 0.01% 315
2024
Q3
$391K Buy
4,736
+449
+10% +$33.5K 0.01% 331
2024
Q2
$301K Buy
4,287
+53
+1% +$3.78K 0.01% 348
2024
Q1
$314K Buy
4,234
+386
+10% +$26.9K 0.01% 342
2023
Q4
$254K Buy
3,848
+228
+6% +$14.3K 0.01% 350
2023
Q3
$228K Buy
+3,620
New +$225K 0.01% 328
2017
Q2
Sell
-208
Closed -$10K 327
2017
Q1
$10K Buy
+208
New +$9.92K ﹤0.01% 434

Other funds holding MET

Crestwood Advisors Group's MET Position: Q1 2026 in Review

Crestwood Advisors Group increased its MetLife (MET) stake by 4.1% in Q1 2026, buying an estimated $22.8K and bringing the position to 7,771 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #400.

Crestwood Advisors Group first reported a position in MET in Q1 2017 and has held it in 12 quarters since. The position peaked at $589K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Crestwood Advisors Group held 7,771 shares of MetLife worth $550K as of Q1 2026.
  • Crestwood Advisors Group bought 305 MetLife shares in Q1 2026, an estimated $22.8K.
  • MetLife made up 0.01% of Crestwood Advisors Group's portfolio in Q1 2026, its #400 holding.
  • Crestwood Advisors Group first reported a position in MetLife in Q1 2017 and has held it in 12 quarters since.
  • Crestwood Advisors Group's MetLife position peaked at $589K in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.